In response to rising consumer complaints, India's drug regulator is set to implement new labelling norms for medicines that prioritise readability and help make informed choices ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Nearly three-quarters of consumers surveyed believed they could recognize a private label when making a purchase, yet 72% ...

Plaintiffs argued the statute would indirectly ban abortion medications by threatening providers with disciplinary action for ...

As temperatures rise, so does the risk of heat-related illness – especially for people taking certain prescription drugs.